Impact of Recent Findings on Study Design of Future Autism Clinical Trials

No abstract is available for this paper.

• Publication year

  2004

• Venue

  CNS Spectrums

• Publication date

  2004-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1017/S109285290000835XPMID 14999175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risperidone in children with autism and serious behavioral problems.

  2002cited by this paper
• Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity.

  2001cited by this paper
• Incorporating language phenotypes strengthens evidence of linkage to autism.

  2001cited by this paper
• Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

  2001cited by this paper
• An open trial of divalproex sodium in autism spectrum disorders.

  2001cited by this paper
• Multisite, double-blind, placebo-controlled trial of porcine secretin in autism.

  2001cited by this paper
• Incorporating language phenotypes strengthens evidence of linkage to autism.

  2001cited by this paper
• A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism.

  2001cited by this paper
• Secretin and Autism: A Two-Part Clinical Investigation

  2000cited by this paper
• LACK OF BENEFIT OF A SINGLE DOSE OF SYNTHETIC HUMAN SECRETIN IN THE TREATMENT OF AUTISM AND PERVASIVE DEVELOPMENTAL DISORDER

  2000cited by this paper
• Effect of secretin on children with autism: a randomized controlled trial

  2000cited by this paper
• 007 Secretin and autism: A two part clinical investigation

  1999cited by this paper
• Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.

  1999cited by this paper
• Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs.

  1996cited by this paper
• A controlled trial with ORG 2766, an ACTH-(4-9) analog, in 50 relatively able children with autism.

  1996cited by this paper
• Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

  1994cited by this paper
• J Neuropsychiatry Clin Neurosci

  1992cited by this paper
• Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior.

  1991cited by this paper
• Fenfluramine treatment of twenty children with autism

  1989cited by this paper
• A depression rating scale for children.

  1979cited by this paper
• A Rating Scale for Mania: Reliability, Validity and Sensitivity

  1978cited by this paper

• A potential strategy for improving offspring behavior in maternal immune activation: Amantadine‐mediated suppression of neuroinflammation

  2025cites this paper
• The Internal Structure of the Aberrant Behavior Checklist Irritability Subscale: Implications for Studies of Irritability in Treatment-Seeking Youth With Autism Spectrum Disorders.

  2020cites this paper
• Meta-analysis: Pharmacologic Treatment of Restricted and Repetitive Behaviors in Autism Spectrum Disorders.

  2020cites this paper
• The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder

  2019cites this paper
• Camel Milk as a Potential Nutritional Therapy in Autism

  2017cites this paper
• Regulatory Forum Opinion Piece*

  2016cites this paper
• Effect of camel milk on thymus and activation-regulated chemokine in autistic children: double-blind study

  2014cites this paper
• Biomarkers in autism spectrum disorder: the old and the new

  2013cites this paper
• A Preliminary Study for the Rating of Pharmacological Effect with Aberrant Behavior Checklist in Children with Autistic Disorder

  2013cites this paper
• Two years’ outcome of autism in a sample of Egyptian and Saudi children: a comparative prospective naturalistic study

  2013cites this paper
• Psychopharmacology of Aggression in Children and Adolescents with Autism: A Critical Review of Efficacy and Tolerability

  2008cites this paper
• Offering to Share: How to Put Heads Together in Autism Neuroimaging

  2008influential citation
• Measurement of problem behaviour during medication evaluations.

  2008cites this paper
• Early pharmacological treatment of autism: a rationale for developmental treatment.

  2007cites this paper
• Factor Analysis of the Aberrant Behavior Checklist in Individuals with Autism Spectrum Disorders

  2007cites this paper
• Interventions éducatives, pédagogiques et thérapeutiques proposées dans l'autisme

  2007cites this paper
• Use of Atypical Antipsychotics in the Treatment of Autistic Disorder

  2007cites this paper
• The status of pharmacotherapy for autism spectrum disorders

  2007cites this paper
• Memantine as Adjunctive Therapy in Children Diagnosed With Autistic Spectrum Disorders: An Observation of Initial Clinical Response and Maintenance Tolerability

  2007cites this paper
• ADouble-Blind Placebo-Controlled Pilot Study of Olanzapine in Childhood/Adolescent Pervasive Developmental Disorder

  2006cites this paper
• Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.

  2006cites this paper
• Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study

  2006cites this paper
• Genetic and phenotypic dissection of autism susceptibility

  2005cites this paper